Überblick
Brett A. Schweers, PhD,* focuses on intellectual property matters in the biotech, pharmaceutical, medical device, chemical and mechanical engineering industries. He garners patent protection for client technologies and manages multiple international patent portfolios to ensure timely filing of responsive materials.
Brett assists clients in drafting patent applications, office action responses and additional correspondence with the US Patent and Trademark Office. He is also skilled at analyzing competitive technologies to inform clients of the strengths and weaknesses of intellectual property estates for use in potential negotiations.
With nearly a decade of experience as a registered patent agent, Brett has extensive experience in patent protection. He has secured protection for his client’s leading pain treatment drug, which achieved numerous US and international patents allowing clients to pursue investment capital and FDA approval. Brett has also enabled clients to expand and/or focus patent portfolios with strategic management decisions related to optimizing patent coverage of disclosed and commercially relevant technologies.
*Non-lawyer professional
Ausgewählte Referenzmandate
- Garnered global patent protection for client’s abuse resistant opioid pain treatment pharmaceutical; assisted in associated FDA approval procedures*
- Obtained patent protection for client’s antibody based cancer therapies*
- Achieved patent protection for client’s “green” technology platform for personal care products, paints, coatings, and adhesives*
- Procured patent protection for client’s mesenchymal stem cell based wound healing therapies*
- Performed patent landscape analysis allowing client to diligently enter next generation sequencing marketplace*
*Matter handled prior to joining McDermott
Qualifikation
Education
Rice University, PhD, Biochemistry and Cell Biology, 2002
University of Houston, BS, Biology, cum laude, 1996
Courts/Agencies
US Patent and Trademark Office
